share_log

Needham Reiterates Buy on Inozyme Pharma, Maintains $23 Price Target

Needham Reiterates Buy on Inozyme Pharma, Maintains $23 Price Target

Needham重申买入Inozyme Pharma,维持23美元的目标股价
Benzinga ·  05/08 06:17

Needham analyst Joseph Stringer reiterates Inozyme Pharma (NASDAQ:INZY) with a Buy and maintains $23 price target.

Needham分析师约瑟夫·斯金格重申Inozyme Pharma(纳斯达克股票代码:INZY)的买入,并维持23美元的目标股价。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发